Oncomine databases on survival of patients suffering from glioblastomas (GBM) showed that disturbed PRG3 levels (> 3 and < −1.5 from normalized log2 median level) are associated with shorter survival outcome compared to human GBM patients with median PRG3 expression (Figure 1F). This evidence concerns the gene PRG3 and glioblastoma.